Silver Oak Securities Incorporated Buys 313 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Silver Oak Securities Incorporated lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 17.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,097 shares of the medical equipment provider’s stock after buying an additional 313 shares during the period. Silver Oak Securities Incorporated’s holdings in Intuitive Surgical were worth $1,031,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Brighton Jones LLC grew its stake in Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after buying an additional 731 shares during the last quarter. Union Bancaire Privee UBP SA acquired a new position in Intuitive Surgical in the fourth quarter valued at about $6,509,000. Bank of Stockton raised its position in shares of Intuitive Surgical by 13.5% in the 4th quarter. Bank of Stockton now owns 1,161 shares of the medical equipment provider’s stock valued at $606,000 after acquiring an additional 138 shares during the period. Bank Pictet & Cie Europe AG boosted its position in shares of Intuitive Surgical by 0.5% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider’s stock worth $99,678,000 after purchasing an additional 883 shares in the last quarter. Finally, D.A. Davidson & CO. grew its stake in Intuitive Surgical by 0.9% in the fourth quarter. D.A. Davidson & CO. now owns 13,198 shares of the medical equipment provider’s stock valued at $6,889,000 after acquiring an additional 115 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, SVP Mark Brosius sold 216 shares of the business’s stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the transaction, the senior vice president now directly owns 907 shares of the company’s stock, valued at approximately $510,740.77. The trade was a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Gary Loeb sold 1,700 shares of the stock in a transaction that occurred on Friday, April 25th. The stock was sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the transaction, the executive vice president now directly owns 2,245 shares of the company’s stock, valued at $1,152,089.10. This represents a 43.09% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 4,998 shares of company stock worth $2,611,577 in the last three months. 0.70% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

ISRG has been the topic of a number of recent research reports. Barclays lowered their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a report on Thursday, April 24th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Thursday, June 5th. Deutsche Bank Aktiengesellschaft downgraded Intuitive Surgical from a “hold” rating to a “sell” rating and dropped their price objective for the stock from $515.00 to $440.00 in a research report on Monday, June 9th. Royal Bank Of Canada decreased their target price on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. Finally, BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the stock a “buy” rating in a report on Monday, April 14th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $588.95.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $509.49 on Thursday. Intuitive Surgical, Inc. has a 1 year low of $413.82 and a 1 year high of $616.00. The stock has a market capitalization of $182.61 billion, a P/E ratio of 74.71, a P/E/G ratio of 5.43 and a beta of 1.67. The company has a 50-day moving average price of $527.31 and a 200-day moving average price of $537.92.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same quarter in the previous year, the firm earned $1.50 earnings per share. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.